Antimicrobial resistance (AMR) is one of the biggest threats facing the world but arguably not enough is being done by both pharma companies and governments around the world.
antibiotics
Last year, biopharmaceutical company Helperby announced a collaboration with the University of California to develop the next generation of combination antibiotics.